<?xml version="1.0"?>
<npl:medprod xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mpa="urn:schemas-npl:mpa:12" xsi:schemaLocation="urn:schemas-npl:instance:12 ../schemas/npl-schema_12.0.xsd" xmlns:npl="urn:schemas-npl:instance:12">
  <mpa:nplid>20170111000030</mpa:nplid>
  <npl:names>
    <mpa:medprodname v="Regumate Equine" />
    <mpa:medprodnamelegal v="Regumate Equine" />
  </npl:names>
  <mpa:strength-text>
    <mpa:v>2,2 mg/ml</mpa:v>
  </mpa:strength-text>
  <mpa:pharmaceutical-form-lx v="ORASOL" lexicon="pharmaceutical-form-lx" />
  <npl:organizations>
    <mpa:organization>
      <mpa:organization-lx v="ID15L2O0IN9DTRSSRV" />
      <mpa:organization-role-lx v="MAH" lexicon="organization-role-lx" />
    </mpa:organization>
  </npl:organizations>
  <npl:special-permission-info>
    <mpa:special-permission-nca-approval-country v="DEU" lexicon="country-lx" />
    <mpa:special-permission-idnumber v="400811.00.00" />
  </npl:special-permission-info>
  <mpa:productclass-lx v="LIC" lexicon="productclass-lx" />
  <mpa:prescription-lx v="1" lexicon="prescription-lx" />
  <npl:classifications>
    <mpa:atc-code-lx v="QG03DX90" />
    <mpa:controlled-medicinal-product-lx v="N" lexicon="yesno-lx" />
    <mpa:narcotic-class-lx v="0" lexicon="narcotic-classification-lx" />
  </npl:classifications>
  <npl:flags>
    <mpa:salesstopped v="N" lexicon="yesno-lx" />
    <mpa:biological-medprod-pharmaceutical-legislation v="N" lexicon="yesno-lx" />
    <mpa:antimicrobial v="N" lexicon="yesno-lx" />
    <mpa:reserved-hum v="N" lexicon="yesno-lx" />
  </npl:flags>
  <npl:pharmaceutical-products>
    <npl:pharmaceutical-product id="IDFMG87B11L7HX3SRV">
      <npl:composition>
        <npl:ingredient id="IDFMG87B11L7I0ZSRV" presentation-substance-name="Y">
          <mpa:ingredient-role-lx v="ACTI" lexicon="ingredient-role-lx" />
          <mpa:quantity-unit-alt-lx v="EQ" lexicon="quantity-unit-alt-lx" />
          <mpa:substance-lx v="IDE4POCIU9KHAVERT1" />
        </npl:ingredient>
      </npl:composition>
      <mpa:comp-ref-quantity-lx v="FGE" lexicon="comp-ref-quantity-lx" />
    </npl:pharmaceutical-product>
  </npl:pharmaceutical-products>
  <npl:withdrawal-periods>
    <npl:withdrawal-period comment="Karenstiden gäller vid behandling med Regumate Equine, oral lösning i dosen 0,044 mg/kg/dag (1 ml oral lösning/50 kg kroppsvikt) i 10 dagar. &#xD;&#xA;&#xD;&#xA;Skall inte användas till lakterande djur som producerar mjölk för humankonsumtion.">
      <mpa:withdrawal-tissue-lx v="1" lexicon="withdrawal-tissue-lx" />
      <mpa:withdrawal-period v="9" />
      <mpa:withdrawal-period-unit-lx v="DAYS" lexicon="withdrawal-period-unit-lx" />
      <npl:species-of-animals>
        <mpa:species-of-animal-lx v="9" lexicon="species-of-animal-lx" />
      </npl:species-of-animals>
    </npl:withdrawal-period>
  </npl:withdrawal-periods>
  <npl:packages>
    <npl:package>
      <mpa:nplpackid>20170111100099</mpa:nplpackid>
      <mpa:pack-text>
        <mpa:v>Licensförpackning</mpa:v>
      </mpa:pack-text>
      <npl:prescription>
        <mpa:otc v="N" lexicon="yesno-lx" />
      </npl:prescription>
    </npl:package>
  </npl:packages>
</npl:medprod>
